XML 39 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900
Subsequent Event
6 Months Ended
Mar. 25, 2016
Subsequent Event:  
Subsequent Event

20. Subsequent Event

        On April 4, 2016, we acquired the Creganna Medical group, a global leader in the design and manufacture of minimally invasive delivery and access medical devices, for a cash purchase price of approximately $900 million, net of cash acquired. The transaction is subject to a final working capital adjustment. This business will be reported as part of our Industrial Solutions segment.